Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioSafe Defenses was a private U.S. healthcare-focused materials and antimicrobial technology company developing light-activated disinfectants and surface-protection products for healthcare and other high-contact environments. Its core technology used conjugated polyelectrolytes designed to inactivate bacteria, fungi, and viruses, including applications in disposable wipes, coatings, textiles, bandages, and medical-device surfaces. The company appears to have focused primarily on infection prevention rather than therapeutics, with its lead commercialization effort centered on an industrial-grade antimicrobial wipe for healthcare settings. BioSafe Defenses originated from university-developed technology associated with the University of New Mexico and the University of Florida and sought regulatory progress through EPA-oriented product development. Public company databases currently describe the business as permanently closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioSafe Defenses.